
Heli
Harvala
professori, biolääketieteen laitos
MD, PhD, EUPHEM Alumni, FRCPath
Ota yhteyttä
Julkaisut
Individual patient and donor seroprofiles in convalescent plasma treatment of COVID-19 in REMAP-CAP clinical trial (2025)
Journal of Infection
(A1 Vertaisarvioitu alkuperäisartikkeli tieteellisessä lehdessä )
Characterising the molecular epidemiology of human parechovirus in young infants in the UK and Canada (2024)
Journal of Clinical Virology
Why is polio still a concern, also in Europe? (2024)
Lancet regional health - Europe
Biomarkers of transfusion transmitted occult hepatitis B virus infection: Where are we and what next? (2024)
Reviews in Medical Virology
Changes in Phenotypic and Molecular Features of Naïve and Central Memory T Helper Cell Subsets following SARS-CoV-2 Vaccination (2024)
Vaccines
Epidemiological and Clinical Insights into the Enterovirus D68 Upsurge in Europe 2021-2022 and Emergence of Novel B3-Derived Lineages, ENPEN Multicentre Study (2024)
Journal of Infectious Diseases
Enterovirus A71 and coxsackievirus A6 circulation in England, UK, 2006-2017: A mathematical modelling study using cross-sectional seroprevalence data (2024)
PLoS Pathogens
Reconstruction of the historic time course of blood-borne virus contamination of clotting factor concentrates, 1974-1992. (2024)
Journal of Medical Virology